Corticobasal Syndrome Cbs clinical trials

Explore recruiting corticobasal syndrome cbs clinical trials.

Recruiting corticobasal syndrome cbs studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Corticobasal Syndrome Cbs trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Double-blind, randomised, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Longitudinal study with positron emission tomography using [18F]PI-2620 in primary tauopathies. Proof-of-concept study

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients

Portugal, Czechia, Netherlands, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Corticobasal Syndrome Cbs trials by city

Corticobasal Syndrome Cbs in Toronto Corticobasal Syndrome Cbs in Vancouver Corticobasal Syndrome Cbs in Montreal Corticobasal Syndrome Cbs in Calgary Corticobasal Syndrome Cbs in Edmonton Corticobasal Syndrome Cbs in Ottawa Corticobasal Syndrome Cbs in Winnipeg Corticobasal Syndrome Cbs in Quebec City Corticobasal Syndrome Cbs in Hamilton Corticobasal Syndrome Cbs in Kitchener Corticobasal Syndrome Cbs in London Corticobasal Syndrome Cbs in Halifax Corticobasal Syndrome Cbs in New York Corticobasal Syndrome Cbs in Los Angeles Corticobasal Syndrome Cbs in Chicago Corticobasal Syndrome Cbs in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease